Replies to post #26454 on Intellipharmaceutics International Inc. (IPCI)

[wimuskyfisherman]

Tek- Just one more thing. I personally believe the Seroquel approval is very important for IPCI. I believe it will get them revenue on the order of $3M per quarter for several quarters. I know others will say it is just a generic and presents very little value but in my opinion that is wrong. For a company burning about $3.5M per quarter, additional revenue on the order of $3M per quarter is a very big step.

I also think the PODRAS PH1 trials won't cost that much. They have already specified how they would proceed. I just hope they can get going on them this summer. I think the reason they have not started already is it is all hands on deck to get manufacturing moving for Seroquel.

You mention bad news. Bad news to me at this point would be no Seroquel approval. If that happens, the stock will take a huge hit. On the flip side, if they get the approval, we should see a nice sustained jump in PPS. That is only fair right?

[Tekterra]

Wimusky, that is correct they will have cash to sustain. I am just saying for someone to bet big on IPCi, being able to sustain is not enough.

We're not saying that IPCI is not going to be able to sustain itself with the MNK deal. I mean, when you invest into a company with serious money, aren't you looking at what the return might be say 5 years for now? Right?

We're talking about what IPCI can do to create that return that investors would be looking for. So break even is a great accomplishment, I don't disagree. But, that's not going to bring the kind of return on my investment for me to be putting big money into IPCI, you see what I mean?

Now, if IPCI signs a deal on Rexista, or they have 50 million cash and rapidly advancing PODRAS trails and Regabatin trails, you can bet your cookies institutions will be all over IPCI.